+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging



Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging



Journal of Pharmacology and Experimental Therapeutics 309(3): 959-969



The dopamine transporter (DAT) is a critical recognition site for cocaine and contributes to its significant abuse liability. Accordingly, the development of compounds that target the DAT represents a logical approach in the pharmacological treatment of cocaine abuse. The present study characterized the effects of DAT inhibitors as pretreatments in rhesus monkeys trained to self-administer cocaine under a second-order schedule of i.v. drug delivery. The drugs also were substituted for cocaine to characterize their effectiveness in maintaining drug self-administration. Positron emission tomography neuroimaging with [(18)F]8-(2-[(18)F]fluoroethyl)-2beta-carbomethoxy-3beta-(4-chlorophenyl) nortropane established the DAT occupancy associated with behaviorally relevant doses of each drug. The drugs studied included a selective DAT inhibitor, [1-(2[bis(4-fluorophenyl-) methoxy]ethyl)-4-(3-phenylpropyl)piperazine] bimesylate hydrate (GBR 12909); an inhibitor with equal potency at dopamine and norepinephrine transporters, [3beta-(4-chlorophenyl)tropane-2beta-(3-phenylisoxazol-5-yl)] HCl (RTI-177); and a nonselective inhibitor of dopamine, norepinephrinem and serotonin transporters, [(-)-3beta-(3'-methyl-4-chlorophenyl)tropane-2beta-carboxylic acid methyl ester] tartrate (RTI-112). All drugs produced dose-related reductions in cocaine self-administration. Doses of GBR 12909 and RTI-177 that reduced responding by 50% (ED(50)) resulted in DAT occupancies of 67 +/- 5 and 73 +/- 5%, respectively. In contrast, DAT occupancy was below the limit of detection for the ED(50) dose of RTI-112. Both GBR 12909 and RTI-177 reliably maintained drug self-administration, and DAT occupancies at doses that maintained peak rates of responding were 57 +/- 1 and 92 +/- 7%, respectively. In contrast, RTI-112 failed to maintain robust drug self-administration in any subject. The results indicate that selective DAT inhibitors may require high DAT occupancy to reduce cocaine self-administration and maintain drug self-administration. Moreover, the behavioral profile of DAT inhibitors may be influenced by actions at other monoamine transporters.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 012013798

Download citation: RISBibTeXText

PMID: 14982963

DOI: 10.1124/jpet.103.060293


Related references

Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse 43(1): 78-85, 2001

Characterization of dopamine transporter occupancy by cocaine with positron emission tomography in rhesus monkeys. Society for Neuroscience Abstracts 25(1-2): 1071, 1999

Self-administration of the cocaine analog RTI 113 Relationship to dopamine transporter occupancy determined by PET neuroimaging in monkeys. Drug & Alcohol Dependence 60(Suppl 1): S236, 1 December, 2000

Attenuation of cocaine self-administration by RTI-113 Relation to dopamine transporter occupancy determined by PET in rhesus monkeys. Drug & Alcohol Dependence 60(Suppl 1): S129, 1 December, 2000

Attenuation of cocaine self-administration by RTI-177 Relation to dopamine transporter occupancy determined by PET in rhesus monkeys. FASEB Journal 16(4): A193, March 20, 2002

Attenuation of cocaine self-administration by substituted tropanes Relation to dopamine transporter occupancy determined by PET in rhesus monkeys. Drug & Alcohol Dependence 66(Supplement 1): S104, 2002

INCREASES IN EXTRACELLULAR DOPAMINE ARE CONSISTENT WITH DOPAMINE TRANSPORTER OCCUPANCY FOR SELF - ADMINISTERED DOSES OF COCAINE AN in vivo MICRODIALYSIS AND PET NEUROIMAGING STUDY IN RHESUS MONKEYS. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 119 7, 2002

Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics 320(2): 757-765, 2006

Model for estimating dopamine transporter occupancy and subsequent increase in synaptic dopamine using positron emission tomography and carbon-11-labeled cocaine. Biochemical Pharmacology 53(1): 43-52, 1997

Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys. Psychopharmacology 159(2): 154-160, 2002

Safety, pharmacokinetic, and positron emission tomography evaluation of serotonin and dopamine transporter occupancy following multiple-dose administration of the triple monoamine reuptake inhibitor BMS-820836. Psychopharmacology 232(3): 529-540, 2015

Positron emission tomography of cocaine binding sites on the dopamine transporter. Nida Research Monograph 138: 57-69, 1994

Self-administration of RTI-177 Relationship to dopamine transporter occupancy in monkeys. FASEB Journal 16(4): A193, March 20, 2002

Reinstatement of cocaine self - administration by monoamine transporter inhibitors in Rhesus monkeys. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 687 12, 2003